NCT03875248

Brief Summary

Validation of an existing algorithm designed to estimate blood pressure based on collected optical signals on patients against two reference methods, which are the arterial catheter (arm 1) and the ausculatory sphygmomanometer (arm 2).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 14, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

March 18, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2021

Completed
Last Updated

June 23, 2020

Status Verified

June 1, 2020

Enrollment Period

2.2 years

First QC Date

March 13, 2019

Last Update Submit

June 19, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Confirmation of measurement done with the investigational device

    Arm 1: Comparision of values to invasive reference method (arterial line)

    First 20 minutes

  • Confirmation of measurement done with the investigational device

    Arm 2: Comparision of values to non-invasive reference method (ausculatory sphygmomanometer)

    First 20 minutes

  • Confirmation of measurement done with the investigational device

    Arm 3: Comparision of values to non-invasive reference method (ausculatory sphygmomanometer)

    First 20 minutes

Secondary Outcomes (2)

  • Usability assessment

    First 20 minutes

  • Safety of procedure by assessing inconvenience and adverse events

    First 20 minutes

Study Arms (3)

Arm 1. Blood pressure measurement compared to arterial line

OTHER

Comparative blood pressure measurement with the investigational device and the invasive reference method (arterial line).

Device: Blood pressure measurement

Arm 2. Blood pressure measurement compared to manual cuff

OTHER

Comparative blood pressure measurement in hypertensive patients with the investigational device and the non-invasive reference method (manual cuff).

Device: Blood pressure measurement

Arm 3. Blood pressure measurement compared to manual cuff

OTHER

Comparative blood pressure measurement in pregnant women with the investigational device and the non-invasive reference method (manual cuff).

Device: Blood pressure measurement

Interventions

Measure optically the blood pressure through the use of a smartphone

Arm 1. Blood pressure measurement compared to arterial lineArm 2. Blood pressure measurement compared to manual cuffArm 3. Blood pressure measurement compared to manual cuff

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsOnly pregnant women are eligible to take part in the study arm 3. No gender-based eligibility criteria exist for the recruitment of patients in the first and seconf arm of the study.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent as documented by signature
  • Men or women older than 18 years old
  • Good understanding of written and oral speaking used at the centre where the study will be carried out
  • American Society of Anesthesiology clinical classification Risk (ASA) Class 1-3
  • Scheduled for a general anesthesia
  • Necessitating an arterial catheters for the anesthesia and surgery.

You may not qualify if:

  • Patients that cannot sign informed consent
  • Patients in emergency situation, are not legally competent, cannot understand the situation
  • ASA Risk class 4
  • Dyshythmia like bigeminy, trigeminy, isolated Ventricular Premature Beats (VPB), atrial fibrillation
  • Lesion or deficiency on hand, preventing index obstruction of smartphone's camera
  • Known contact dermatitis to nickel/chromium
  • Informed Consent as documented by signature
  • Men or women older than 18 years old
  • Good understanding of written and oral speaking used at the centre where the study will be carried out
  • Patients that cannot sign informed consent
  • Patients in emergency situation, are not legally competent, cannot understand the situation
  • Known or suspected non-compliance (e.g. drug or alcohol abuse, language problems, psychological disorders, dementia)
  • Known pregnancy
  • Systolic blood pressure difference between two arms \>15mmHg or, diastolic blood pressure difference between two arms \>10mmHg
  • Unstable cardiac condition (myocardial infarction \< 1 week, pulmonary embolism, ventricular arrhythmia, decompensated heart failure)
  • +15 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire Vaudois (CHUV)

Lausanne, Canton of Vaud, 1011, Switzerland

RECRUITING

Hôpital Universitaire de Genève (HUG)

Geneva, 1205, Switzerland

COMPLETED

Related Publications (2)

  • Almeida P, Cuenoud A, Hoang H, Othenin-Girard A, Salhi N, Kothe A, Christen U, Schoettker P. Accuracy of the smartphone blood pressure measurement solution OptiBP to track blood pressure changes in pregnant women. J Hypertens. 2025 Apr 1;43(4):665-672. doi: 10.1097/HJH.0000000000003956. Epub 2025 Feb 7.

  • Degott J, Ghajarzadeh-Wurzner A, Hofmann G, Proenca M, Bonnier G, Lemkaddem A, Lemay M, Christen U, Knebel JF, Durgnat V, Burnier M, Wuerzner G, Schoettker P. Smartphone based blood pressure measurement: accuracy of the OptiBP mobile application according to the AAMI/ESH/ISO universal validation protocol. Blood Press Monit. 2021 Dec 1;26(6):441-448. doi: 10.1097/MBP.0000000000000556.

MeSH Terms

Interventions

Blood Pressure Determination

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisPhysical Examination

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: The arm 1 of the study has been designed as a multicentric prospective pilot study. The arm 2 of the study has been designed as a monocentric prospective pilot study. The arm 3 of the study has been designed as a monocentric prospective pilot study.
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Head of Anaesthesia Unit

Study Record Dates

First Submitted

March 13, 2019

First Posted

March 14, 2019

Study Start

March 18, 2019

Primary Completion

June 14, 2021

Study Completion

June 14, 2021

Last Updated

June 23, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations